The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential.
Leeson
P D
PD
Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex, U.K.
Iversen
L L
LL
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D014150:Antipsychotic Agents / Q000494:pharmacology; D001665:Binding Sites; D003071:Cognition / Q000187:drug effects; D005998:Glycine / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D007736:Kynurenic Acid / Q000494:pharmacology; D018696:Neuroprotective Agents / Q000494:pharmacology; D011760:Pyrrolidinones / Q000494:pharmacology; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors* / Q000502:physiology; D013329:Structure-Activity Relationship
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D018696:Neuroprotective Agents; D011760:Pyrrolidinones; D016194:Receptors, N-Methyl-D-Aspartate; C001369:1-hydroxy-3-amino-2-pyrrolidone; D007736:Kynurenic Acid; D005998:Glycine